ALFA FinderBSE filing, NSE: TRABI. Summary written from the filing by ALFA Finder's alert engine.
Transgene Biotek Ltd: key numbers
- Share price
- ₹2.55
- Market cap
- ₹19.32 Cr
- Revenue (annual)
- ₹0.21 Cr
- Net profit (annual)
- ₹-1.65 Cr
- P/E (TTM)
- -12.0×Sector 54.7×
- Promoter holding
- 23.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Transgene Biotek Ltd
All →Transgene Biotek Annual General Meeting
Transgene Biotek closed its register of members from December 24 to 30, 2026 for its 36th AGM. The e-voting cut-off date is December 23, 2026.
Transgene Biotek Q2 FY27 Results: Net Profit ₹0 Cr
Transgene Biotek Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Transgene Biotek Board Meeting Date
Transgene Biotek will hold a board meeting on 13 November 2026 to consider quarterly results, AGM notice, and other matters. The agenda is proposed only, and no outcomes have been approved yet.
Transgene Biotek Other Announcement
Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.
- Execution
- 2 months
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Transgene Biotek Board Meeting Outcome
Transgene Biotek Limited appointed M/s. Eswara Rao & Co. as the new statutory auditor to fill a casual vacancy, subject to shareholder approval.
Other management change announcements
All →Archidply Decor Management Change
Archidply Decor's board appointed Mr. Devesh Daga as Additional Executive Director, subject to shareholder approval. He is the son of the Managing Director.
ICICI Prudential Asset Management Company Management Change
ICICI Prudential AMC disclosed that Senior Management Personnel Abhijit Shah opted for early retirement, effective close of business November 27, 2026. The change is a senior management departure.
India Glycols Management Change
India Glycols re-appointed Executive Director Alok Singhal for three years from 1 December 2026, subject to shareholder approval. He has served the company since 1991.
- Execution
- 3 years from 1 December 2026 to 30 November 2029
Bajaj Hindusthan Sugar Management Change
Bajaj Hindusthan Sugar's board approved by circular resolution an EGM to appoint Mrs. Priyanka Baya as an Independent Woman Director. It also approved the EGM notice, a scrutinizer and an e-voting agency.
Arvind SmartSpaces Management Change
Arvind SmartSpaces announced the resignation of Mr. Vishal Balesh, Chief Sales & Marketing Officer, effective 13 November 2026 after close of business. The resignation is to pursue a career opportunity outside the Group.
Saroja Pharma Industries India Management Change
Saroja Pharma's statutory auditor, Pravin Chandak & Associates, revised its resignation to be effective 15 November 2026. The auditor cites pre-occupation in other professional assignments as the reason.